(Q40621262)

22 September 2017

Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A526002

9 July 2022

main subject

Mycobacterium fortuitum

object named as

Mycobacterium fortuitum

1 reference

https://api.crossref.org/works/10.1128/AAC.16.5.611

inferred from title

Mycobacterium fortuitum

0 references

1 reference

25 June 2023

2

J. R. Dalovisio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A526002

9 July 2022

3

G. A. Pankey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A526002

9 July 2022

author name string

Wallace RJ Jr

series ordinal

1

1 reference

PMCID

352914

22 September 2017

R. J. Wallace

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A526002

9 July 2022

language of work or name

English

0 references

publication date

1 November 1979

1 reference

PMCID

352914

full work available at URL

22 September 2017

https://europepmc.org/articles/PMC352914

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A526002

https://europepmc.org/articles/PMC352914?pdf=render

9 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A526002

https://journals.asm.org/doi/pdf/10.1128/AAC.16.5.611

9 July 2022

1 reference

https://api.crossref.org/works/10.1128/AAC.16.5.611

Antimicrobial Agents and Chemotherapy

25 June 2023

published in

1 reference

22 September 2017

16

1 reference

22 September 2017

5

1 reference

22 September 2017

611-614

1 reference

Antimicrobial Susceptibility Testing of Mycobacterium fortuitum Complex

22 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352914

Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents

22 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352914

In Vitro Susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to Amikacin

25 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352914

Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/526002

12 December 2020

inferred from PubMed ID database lookup

In-Vitro Activity of Erythromycin against Atypical Mycobacteria

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/526002

12 December 2020

inferred from PubMed ID database lookup

Clinical significance of Mycobacterium fortuitum infections in pulmonary disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/526002

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.16.5.611

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

PMCID

352914